$33.08
-0.11-0.33%
Last update: Oct 23, 4:37 PM
Castle Biosciences Inc (CSTL) Stock Price, Quote, News & History
CSTLNASDAQ
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued...
You can purchase shares of Castle Biosciences (NASDAQ:CSTL) through any online brokerage.
Other companies in Castle Biosciences’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
Castle Biosciences has a consensus price target of $42.30.
The stock price for Castle Biosciences (NASDAQ: CSTL) is $33.08 last updated October 23, 2026 at 4:37 PM EDT.
There are no upcoming dividends for Castle Biosciences.
Castle Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Castle Biosciences.
Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes...
